Important Notices

On Nov. 24, 2025, Abbott Diabetes Care initiated a voluntary recall of select lots of the FreeStyle Libre 3 continuous glucose monitoring sensor.

On Nov. 6, 2025, Fresenius Kabi initiated a voluntary nationwide recall of three lots of famotidine injection, USP, 20mg per 2mL (10mg per mL).

On Nov. 6, 2025, Grifols Therapeutics initiated a voluntary recall of one lot of Gammaked® (immune globulin injection [human]).

Grifols Therapeutics LLC issued a voluntary withdrawal of two lots of Gamunex-C® (immune globulin injection [human], 10%) on Sept. 30, 2025, following a rise in reported hypersensitivity reactions associated with the affected vials.

On Aug. 27, 2025, Unichem Pharmaceuticals issued a recall for one lot of cyclobenzaprine hydrochloride 10mg tablets

On Aug. 26, 2025, B. Braun recalled Sterile Water for Injection and Sodium Chloride 0.9% Irrigation Solution due to the chance of fluid leaking from the port site.

On Aug. 11, 2025, Pfizer initiated a recall of Octagam® Immune Globulin Intravenous (Human) 10% Liquid Preparation due to the potential for damaged bottles during transport.

On Aug. 20, 2025, B. Braun issued a recall notification for two injectable products, Sodium Chloride 0.9% E3 Injection (12 x 1000 mL) and Lactated Ringer’s Injection (12 x 1000 mL).

On Aug. 13, 2025, Celltrion USA initiated a recall of one lot of Steqeyma® (ustekinumab-stba) 90 mg/mL injection due to incorrect assembly and release into the market.

On Aug. 8, 2025, Grifols Therapeutics LLC withdrew two lots of Gamunex-C® (immune globulin injection [human], 10% caprylate/chromatography purified) 20G vials to the consumer level